脑与脊髓联合FDG PET可鉴别肌萎缩侧索硬化与其模仿疾病
98例疑似肌萎缩侧索硬化(ALS)患者接受脑与脊髓[18F]-FDG PET-CT,经平均18.1±8.4个月随访确诊ALS 62例、ALS模仿疾病23例、变异型运动神经元病13例。ALS与模仿疾病脑代谢相似,颈段和胸段脊髓代谢存在显著差异;仅用脑代谢、仅用脊髓代谢及两者联合的支持向量机分类平均判别准确率分别为65.4%、80.0%和81.5%。
要点
- 疑似ALS患者行脑与脊髓[18F]-FDG PET-CT,联合支持向量机分类平均判别准确率为81.5%。
- 仅用脊髓代谢判别准确率80.0%,仅用脑代谢为65.4%。
- ALS与ALS模仿疾病颈段脊髓标准化摄取值分别为2.1±0.5与1.9±0.4,胸段为1.8±0.3与1.5±0.3。
核心结论
- 脑与脊髓FDG PET-CT联合支持向量机分类可作为真实临床环境中鉴别ALS与ALS模仿疾病的有用判别生物标志物。
研究设计与样本
- 疑似ALS患者98例(64.8±11岁,男性61例)接受脑与脊髓[18F]-FDG PET-CT扫描。
- 经纵向随访(平均18.1±8.4个月)确诊ALS 62例(67.8±10岁,男性35例),诊断为其他疾病即ALS模仿疾病23例(60.9±12.9岁,男性17例),变异型运动神经元病13例,其中原发性侧索硬化4例(53.6±2.5岁,男性2例)、进行性肌萎缩9例(58.4±7.3岁,男性7例)。
- 脊髓代谢经手动和自动分割测定,行基于感兴趣区和体素的比较,并采用支持向量机方法评估区域脑代谢、脊髓代谢及两者联合的判别能力。
主要发现
- ALS模仿疾病与ALS的脑代谢非常相似,而颈段和胸段脊髓代谢存在显著差异(标准化摄取值:颈段ALS 2.1±0.5 vs ALS模仿疾病1.9±0.4;胸段ALS 1.8±0.3 vs ALS模仿疾病1.5±0.3)。
- ALS模仿疾病与原发性侧索硬化/进行性肌萎缩的脑和脊髓代谢均非常相似,故合并各组进行准确率分析。
- 仅用脑代谢、仅用脊髓代谢及两者联合的平均判别准确率分别为65.4%、80.0%和81.5%。
关键数值与推荐
- 仅用脑代谢的平均判别准确率为65.4%。
- 仅用脊髓代谢的平均判别准确率为80.0%。
- 联合脑与脊髓代谢的平均判别准确率为81.5%。
临床怎么用
- 在真实临床诊断环境中,脑与脊髓[18F]-FDG PET-CT联合支持向量机分类可用于鉴别ALS与ALS模仿疾病。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder with on average a 1-year delay between symptom onset and diagnosis. Studies have demonstrated the value of [18F]-FDG PET as a sensitive diagnostic biomarker, but the discriminatory potential to differentiate ALS from patients with symptoms mimicking ALS has not been investigated. We investigated the combination of brain and spine [18F]-FDG PET-CT for differential diagnosis between ALS and ALS mimics in a real-life clinical diagnostic setting. METHODS: Patients with a suspected diagnosis of ALS (n = 98; 64.8 ± 11 years; 61 M) underwent brain and spine [18F]-FDG PET-CT scans. In 62 patients, ALS diagnosis was confirmed (67.8 ± 10 years; 35 M) after longitudinal follow-up (average 18.1 ± 8.4 months). In 23 patients, another disease was diagnosed (ALS mimics, 60.9 ± 12.9 years; 17 M) and 13 had a variant motor neuron disease, primary lateral sclerosis (PLS; n = 4; 53.6 ± 2.5 years; 2 M) and progressive muscular atrophy (PMA; n = 9; 58.4 ± 7.3 years; 7 M). Spine metabolism was determined after manual and automated segmentation. VOI- and voxel-based comparisons were performed. Moreover, a support vector machine (SVM) approach was applied to investigate the discriminative power of regional brain metabolism, spine metabolism and the combination of both. RESULTS: Brain metabolism was very similar between ALS mimics and ALS, whereas cervical and thoracic spine metabolism was significantly different (in standardised uptake values; cervical: ALS 2.1 ± 0.5, ALS mimics 1.9 ± 0.4; thoracic: ALS 1.8 ± 0.3, ALS mimics 1.5 ± 0.3). As both brain and spine metabolisms were very similar between ALS mimics and PLS/PMA, groups were pooled for accuracy analyses. Mean discrimination accuracy was 65.4%, 80.0% and 81.5%, using only brain metabolism, using spine metabolism and using both, respectively. CONCLUSION: The combination of brain and spine FDG PET-CT with SVM classification is useful as discriminative biomarker between ALS and ALS mimics in a real-life clinical setting.
引用
- Van Weehaeghe D, Devrome M, Schramm G, et al. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics. Eur J Nucl Med Mol Imaging. 2020. PMID: 32314027. doi:10.1007/s00259-020-04786-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。